Get the Stockscreener App
44.50
10.10%
-5.00
After Hours:
44.75
0.25
+0.56%
Tempus Ai Inc stock is traded at $44.50, with a volume of 3.06M.
It is down -10.10% in the last 24 hours and down -15.94% over the past month.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
See More
Previous Close:
$49.50
Open:
$48.8
24h Volume:
3.06M
Relative Volume:
2.95
Market Cap:
$6.65B
Revenue:
$595.57M
Net Income/Loss:
$-720.86M
P/E Ratio:
-
EPS:
-
Net Cash Flow:
$-324.53M
1W Performance:
-1.59%
1M Performance:
-15.94%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$39.34
$48.81
1-Week Range:
$39.34
$49.64
52-Week Range:
$22.89
$77.00
Tempus Ai Inc Stock (TEM) Company Profile
Name
Tempus Ai Inc
Sector
Industry
Phone
800-976-5448
Address
600 WEST CHICAGO AVENUE, CHICAGO
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-24 | Initiated | Piper Sandler | Neutral |
| Jul-09-24 | Initiated | BofA Securities | Buy |
| Jul-09-24 | Initiated | JP Morgan | Overweight |
| Jul-09-24 | Initiated | Longbow | Buy |
| Jul-09-24 | Initiated | Loop Capital | Buy |
| Jul-09-24 | Initiated | Morgan Stanley | Overweight |
| Jul-09-24 | Initiated | Needham | Buy |
| Jul-09-24 | Initiated | Stifel | Buy |
| Jul-09-24 | Initiated | TD Cowen | Buy |
| Jul-09-24 | Initiated | William Blair | Outperform |
View All
Tempus Ai Inc Stock (TEM) Latest News
Ambry Genetics Being Acquired by Tempus AI for $600M - Orange County Business Journal
Tempus AI (NASDAQ:TEM) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Needham raises Tempus AI stock target on Q3 results, acquisition - Investing.com
Needham raises Tempus AI stock target on Q3 results, acquisition By Investing.com - Investing.com UK
Tempus AI Shows Market Leadership With Jump To 85 RS Rating - Investor's Business Daily
Tempus: Q3 Earnings Snapshot - Barchart
Tempus AI Inc Reports 33% Revenue Growth to $180.9 Million in Q3 2024 Amid Strategic Acquisition - GuruFocus.com
Konica Minolta Sells Ambry Genetics to Tempus AI - TipRanks
Tempus AI Agrees to Acquire Ambry Genetics - MarketWatch
Tempus buying genetics lab company for $600 million - Crain's Chicago Business
Tempus Reports Third Quarter 2024 Results and Agreement to Acquire Ambry Genetics - StockTitan
Tempus to Report Third Quarter 2024 Financial Results on November 4 - 01Net
International Assets Investment Management LLC Buys 70,700 Shares of Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Cathie Wood's ARK offloads Palantir and Tesla stock, buys Tempus and Twist - Investing.com
Tempus AI Shows Improved Relative Price Performance; Still Shy Of Benchmark - MSN
Tempus, Northwestern train AI in finding cardiovascular risk - Crain's Chicago Business
Tempus and Northwestern Medicine Announce Collaboration to Bring Practical Application of AI to Healthcare - Business Wire
Tempus AI (TEM) to Release Quarterly Earnings on Thursday - MarketBeat
Tempus AI (NASDAQ:TEM) Trading 6.4% HigherHere's What Happened - MarketBeat
Tempus exec-founded biotech startup raises $62 million - Crain's Chicago Business
Tempus: Attempting To Lead The AI Revolution In Healthcare (NASDAQ:TEM) - Seeking Alpha
Tempus Announces Collaboration With JW Pharmaceutical to Apply Real-World Data and Biological Modeling to Enhance Early Research and Development - Yahoo Finance
Dakota Wealth Management Makes New $1.19 Million Investment in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Tempus AI (NASDAQ:TEM) Stock Price Down 3.4%Time to Sell? - MarketBeat
Tempus to Report Third Quarter 2024 Financial Results on November 7 - StockTitan
Cathie Wood's ARK offloads Robinhood stock, buys Tempus AI By Investing.com - Investing.com Nigeria
Cathie Wood's ARK offloads Robinhood stock, buys Tempus AI - Investing.com
Avacta partners Tempus AI to boost cancer therapy development - Yahoo Finance
Avacta and Tempus partner for AI-driven oncology drug development By Investing.com - Investing.com Australia
Avacta and Tempus partner for AI-driven oncology drug development - Investing.com
Avacta and Tempus Enter Strategic Collaboration to Advance AI-Driven Drug Development in Oncology - The Manila Times
Avacta and Tempus Join Forces to Advance AI-Driven Drug Development in Oncology - AskTraders
Avacta Group PLC (AIM:AVCT) Avacta and Tempus Enter Strategic Collaboration - Share Talk
Avacta in Wetherby launches AI collaboration with Tempus AI Inc - The Business Desk
Tempus AI (NASDAQ:TEM) Stock Price Up 7.3%Still a Buy? - MarketBeat
The Billionaire Behind Groupon Is Making A Fortune In An Industry He Swore He’d Never Enter - Forbes
Tempus AI, Inc. (NASDAQ:TEM) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Cathie Wood's ARK sells Moderna, buys more Intellia and Tempus stock - Investing.com
11,188 Shares in Tempus AI, Inc. (NASDAQ:TEM) Bought by Renaissance Capital LLC - MarketBeat
Cathie Wood's ARK ETF focuses on Tempus AI and AMD stock - Investing.com Australia
Tempus AI (NASDAQ:TEM) PT Raised to $57.00 - MarketBeat
Tempus AI Launches olivia App for Patient Health Management - The Healthcare Technology Report.
Loop Capital sees strong growth potential in Tempus AI stock, highlighting innovative healthcare platform - Investing.com
Exchange Traded Concepts LLC Purchases New Position in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Tempus AI, Inc (TEM): A Bull Case Theory - Insider Monkey
Tempus AI (NASDAQ:TEM) Stock Price Up 6.7%Still a Buy? - MarketBeat
Tempus AI (NASDAQ:TEM) Stock Price Down 4.4%Here's Why - MarketBeat
Millennium Management LLC Takes Position in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Tempus Ai Inc Stock (TEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.07%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):